News
34m
Money Talks News on MSNWegovy Fallout: How Novo’s Exit Hits Your Wallet and Waistline
Novo Nordisk announced it is cutting ties with telehealth giant Hims & Hers Health, pulling its blockbuster drug Wegovy from the platform after accusing the company of selling “illegitimate, knockoff ...
University of Florida researchers said a new study could lead to a universal cancer shot, while digital health earnings ...
If you suffered losses exceeding $50,000 in Hims between April 29, 2025 and June 22, 2025 and would like to discuss your ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results